These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6048657)

  • 41. Infectivity and pathogenicity of drug-resistant strains of tubercle bacilli studied by aerogenic infection of guinea pigs.
    Cohn ML; Davis CL
    Am Rev Respir Dis; 1970 Jul; 102(1):97-100. PubMed ID: 4316799
    [No Abstract]   [Full Text] [Related]  

  • 42. [Chemotherapy of tuberculosis].
    Luu Duc Cuong
    Biol Med (Paris); 1970; 59(6):471-561. PubMed ID: 4325981
    [No Abstract]   [Full Text] [Related]  

  • 43. Studies on atypical mycobacteria. X. Experimental approach to the etiology of atypical mycobacteriosis.
    Ogawa T; Motomura K
    Kekkaku; 1971 Sep; 46(9):365-70. PubMed ID: 5122006
    [No Abstract]   [Full Text] [Related]  

  • 44. [ANTIMICROBIAL SCREEN IN PHTHISIOLOGICAL SURGERY].
    SNAJDR V; KRAKORA P; FISER F; CHODOUNSKA V
    Rozhl Chir; 1963 Oct; 42():712-20. PubMed ID: 14119837
    [No Abstract]   [Full Text] [Related]  

  • 45. Bactericidal activity of streptomycin, isoniazid, rifampin, ethambutol, and pyrazinamide alone and in combination against Mycobacterium Tuberculosis.
    Dickinson JM; Aber VR; Mitchison DA
    Am Rev Respir Dis; 1977 Oct; 116(4):627-35. PubMed ID: 411404
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The results of treatment in patients with cultures resistant to streptomycin, isoniazid and PAS: a five-year follow-up.
    Tousek J; Jancik E; Zelenka M; Jancikova-Máková M
    Tubercle; 1967 Mar; 48(1):27-31. PubMed ID: 4291925
    [No Abstract]   [Full Text] [Related]  

  • 47. [DRUG TREATMENT OF RENAL TUBERCULOSIS].
    TUOVINEN PI; SUTINEN S
    Suom Laakaril; 1964 Aug; 19():1629-38. PubMed ID: 14179990
    [No Abstract]   [Full Text] [Related]  

  • 48. A ten-year clinical experience with Mycobacterium kansasii.
    Rauscher CR; Kerby G; Ruth WE
    Chest; 1974 Jul; 66(1):17-9. PubMed ID: 4846114
    [No Abstract]   [Full Text] [Related]  

  • 49. [Advances and principles in tuberculostatic therapy].
    Bethge H
    Internist (Berl); 1971 Aug; 12(8):328-31. PubMed ID: 4328130
    [No Abstract]   [Full Text] [Related]  

  • 50. Rationale for chemotherapy of tuberculosis and current recommendations.
    Kumar L
    Indian Pediatr; 1992 Nov; 29(11):1337-9. PubMed ID: 1294486
    [No Abstract]   [Full Text] [Related]  

  • 51. Interaction aspects of antimycobacterial drugs in the chemotherapy of tuberculosis. I. Role of individual antituberculous drugs in drug regimens used in the chemotherapy of human tuberculosis.
    Trnka L; Tousek J
    Chemotherapy; 1974; 20(3):165-76. PubMed ID: 4136827
    [No Abstract]   [Full Text] [Related]  

  • 52. [Study of primary resistance to antitubercular agents in the Sousse region, 1981-1990].
    Benzarti M; Garrouche A; Jerray M; Hayouni A; Maalel K; Klabi N
    Tunis Med; 1996 Jan; 74(1):23-7. PubMed ID: 9507309
    [No Abstract]   [Full Text] [Related]  

  • 53. Drug resistant pulmonary tuberculosis treated with ethambutol and rifampicin in North East England.
    Somner AR; Selkon JB; Walton M; White AB
    Tubercle; 1971 Dec; 52(4):266-75. PubMed ID: 5143922
    [No Abstract]   [Full Text] [Related]  

  • 54. [THE TREATMENT OF TUBERCULOSIS WITH 2ND LINE DRUGS].
    SCHWARTZ WS
    Sem Med; 1964 Mar; 124():523-34. PubMed ID: 14156390
    [No Abstract]   [Full Text] [Related]  

  • 55. [ANTIMICROBIAL TREATMENT OF TUBERCULOSIS WITH SUBSIDIARY DRUGS. 2ND LINE DRUGS].
    ACEVEDO RC; HERRERO JJ; PILHEU J; RODRIGUEZ E
    Sem Med; 1964 Mar; 124():534-43. PubMed ID: 14156391
    [No Abstract]   [Full Text] [Related]  

  • 56. Primary drug resistance: a continuing study of drug resistance in tuberculosis in a veteran population within the United States. IX. September 1969-September 1970.
    Hobby GL; Johnson PM; Boytar-Papirnyik V
    Am Rev Respir Dis; 1971 Jun; 103(6):842-4. PubMed ID: 4996847
    [No Abstract]   [Full Text] [Related]  

  • 57. Newer knowledge of chemotherapy in the treatment of tuberculosis of bones and joints.
    Friedman B; Kapur VN
    Clin Orthop Relat Res; 1973; (97):5-15. PubMed ID: 4359522
    [No Abstract]   [Full Text] [Related]  

  • 58. [ANTIBACTERIAL TREATMENT IN PATIENTS AFFLICTED WITH PULMONARY TUBERCULOSIS CAUSED BY MYCOBACTERIA RESISTANT TO THE MAJOR CHEMO-ANTIBIOTICS].
    LUCCHESI M; BANCALE A; ROSSI P
    Ann Ist Carlo Forlanini; 1963; 23():235-52. PubMed ID: 14122048
    [No Abstract]   [Full Text] [Related]  

  • 59. [Treatment of pulmonary tuberculosis in patients resistant to major drugs with second line drugs].
    Ibarra JP; Piñeyro J; Trenchi A; Tarallo NH; Lanne de Farriols ME; Cuñarro de Gimeno G; Fernández Latorre I
    Hoja Tisiol; 1967; 24(1):5-88. PubMed ID: 4308762
    [No Abstract]   [Full Text] [Related]  

  • 60. [Present state of resistance to antibiotics by tuberculous bacilli in Africa (author's transl)].
    Rey JL; Villon A; Menard M; Le Mao G; Albert JP
    Med Trop (Mars); 1979; 39(2):149-54. PubMed ID: 91079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.